30 related articles for article (PubMed ID: 38753562)
21. TATA-binding protein in neurodegenerative disease.
van Roon-Mom WM; Reid SJ; Faull RL; Snell RG
Neuroscience; 2005; 133(4):863-72. PubMed ID: 15916858
[TBL] [Abstract][Full Text] [Related]
22. [SCA17, a novel polyglutamine disease caused by the expansion of polyglutamine tracts in TATA-binding protein].
Nakamura K
Rinsho Shinkeigaku; 2001 Dec; 41(12):1123-5. PubMed ID: 12235815
[TBL] [Abstract][Full Text] [Related]
23. Polyglutamine neurodegeneration: expanded glutamines enhance native functions.
Orr HT
Curr Opin Genet Dev; 2012 Jun; 22(3):251-5. PubMed ID: 22284692
[TBL] [Abstract][Full Text] [Related]
24. Drosophila in the study of hTBP protein interactions in the development and modeling of SCA17.
Montalvo-Méndez RJ; Cárdenas-Tueme M; Reséndez-Pérez D
Gac Med Mex; 2024; 160(1):1-8. PubMed ID: 38753562
[TBL] [Abstract][Full Text] [Related]
25. Molecular Mechanisms and Therapeutics for SCA17.
Liu Q; Pan Y; Li XJ; Li S
Neurotherapeutics; 2019 Oct; 16(4):1097-1105. PubMed ID: 31317427
[TBL] [Abstract][Full Text] [Related]
26. Spinocerebellar Ataxia Type 17 (SCA17).
Toyoshima Y; Takahashi H
Adv Exp Med Biol; 2018; 1049():219-231. PubMed ID: 29427105
[TBL] [Abstract][Full Text] [Related]
27. Genetically modified rodent models of SCA17.
Cui Y; Yang S; Li XJ; Li S
J Neurosci Res; 2017 Aug; 95(8):1540-1547. PubMed ID: 27859490
[TBL] [Abstract][Full Text] [Related]
28. [Advance in research on spinocerebellar ataxia 17].
Zhang J; Gu W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Feb; 31(1):44-7. PubMed ID: 24510561
[TBL] [Abstract][Full Text] [Related]
29. Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.
Zühlke C; Bürk K
Cerebellum; 2007; 6(4):300-7. PubMed ID: 17853080
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
